Abbott Initiates Medical Device Correction For Certain Freestyle Libre® 3 And Freestyle Libre 3 Plus Sensors In The U.s.
Summary Abbott is correcting certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose sensors in the U.S. because some sensors may show inaccurate low blood sugar readings. The correction affects specific batches of these continuous glucose monitoring devices used by people with diabetes.
- Product
- ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide incorrect low glucose readings.
- Reason
- ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide incorrect low glucose readings.
- Category
- medical device recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-01-15
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/745ea1ae-eb90-4a55-a81e-a2fe3fc1dee5